🇺🇸 FDA
Patent

US 12055553

Method for diagnosing risk for inflammatory disease through glycan profiling

granted A61KA61K31/7004A61K31/7008

Quick answer

US patent 12055553 (Method for diagnosing risk for inflammatory disease through glycan profiling) held by The Regents of the University of California expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/7004, A61K31/7008